Cite
HARVARD Citation
Lazarus, R. et al. (2022). Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial. Lancet infectious diseases. 22 (12), pp. 1716-1727. [Online].